Melva Covington has remained instrumental in the continued growth of Sanofi, one of the leading healthcare companies in the United States. She joined the company in 2010 as director of comparative effectiveness & health outcomes. Less than two years later, she was appointed director of evidence translation and operations. Since 2013, Melva Covington has served as project leader of the company's North America R&D hub, which entails addressing how to improve patient recruitment and retention in clinical trials for conditions across the drug development portfolio.
Her focus in 2015, will be to drive deeper into innovations that improve patient-centered care and health outcomes.
As part of her leadership role at Sanofi, Melva Covington oversees an initiative that examines several areas impacting clinical operations, efficiencies and partnerships. She coordinates evidence and business strategies that relate to the value of products in various stages of development, and cultivates clinical and real-world evidence useful for addressing the needs of patients across demographic groups. In all trials and evidence-gathering assignments, she must evaluate the value of research and products relative to their impact, risks and benefits.
Melva Covington pulls from numerous disciplines and fields of study to benefit Sanofi, the community and patients in general. After completing her bachelor of arts at Catholic University of America in Politics and Economics, she earned a master of